FDA has granted “Breakthrough Device” designation to Essilor´s Stellest spectacle lens
Essilor announced that the U.S. Food and Drug Administration (FDA) has granted “Breakthrough Device” designation to its Essilor Stellest spectacle lens, the Company’s new generation lens developed to correct myopia and slow down the progression of myopiain children. The designation of the Essilor’s Stellest spectacle lens as by the FDA, that will lead to further…


